99% High Quality TYRA-300 Powder CAS 2800223-30-5 with Best Price
TDS 129 Inquiries
2800223-30-5
Pharmaceutical Grade
99%
QD
NATURE
Aluminium foil bag,25kg drum
2026-09-03
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionDabogratinib(TYRA-300) , a 3-pyridylindazole analog, is a reversible and selective inhibitor of FGFR3 with an IC50 of 11 nM in Ba/F3 cells. It also exhibit potent activity in human bladder cancer cell lines harboring FGFR3 activating fusions or mutations.CertificatesBasic Info
-
Product Name:
TYRA-300
Other Name:TYRA-300;2,6-Diazaspiro[3.3]heptane, 2-[5-[5-[(1R)-1-(3,5-dichloro-4-pyridinyl)ethoxy]-1H-indazol-3-yl]-2-pyridinyl]-6-(methylsulfonyl)-;(R)-5-(1-(3,5-Dichloropyridin-4-yl)ethoxy)-3-(6-(6-(methylsulfonyl)-2,6-diazaspiro[3.3]heptan-2-yl)pyridin-3-yl)-1H-indazole;TYRA-300(Dabogratinib);Tyra-300 99% Shaanxi Dideu Medichem
CAS No.:2800223-30-5
Molecular Formula:C25H24Cl2N6O3S
InChIKeys:JOAFWIHZEBKYQK-OAHLLOKOSA-N
Molecular Weight:559.47
EC Number:610-261-8
Categories:
Characteristics-
Density:
1.58±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)
Boiling Point:791.2±70.0 °C(predicted)
PKA:11.87±0.40(predicted)
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Weight Loss Peptide,Reta,Tirz,Sema,5 Amino 1mq,Cosmetic raw material,API,SLU-PP-332
-
Location:
Unit D01,3/F., Wong King Industrial Building,No.2 Tai Yau Street, Kowloon
-
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7
-
Total Annual Revenue:
$50 million-$100 million
-
Total Employees:
51-100
-
Year of Establishment:
2012
-
-
Inquiry History129 Inquiries
Country Product Purchase Quantity Date Posted
India
Tyra-300 CAS 2800223-30-5
9 G Jul 8, 2026
United States
TYRA-300 CAS 2800223-30-5
8 G Jul 14, 2026
United States
High Quality TYRA-300 99% powder 2800223-30-5 Shaanxi Dideu Medichem Co.Ltd
8 G Aug 2, 2026
Germany
TYRA-300
5 G Aug 1, 2026
Canada
TYRA 300
1 G Jun 2, 2026
Poland
Tyra-300
15 G Aug 5, 2026
Germany
Tyra 300
2 G Aug 3, 2026
United States
Tyra-300
25 MG Aug 2, 2026
Australia
dabogratinib
1 KG Aug 1, 2026
United States
Anticancer API 99% TYRA-300/TYRA 300/Dabogratinib CAS:2800223-30-5 for R&D
6 G Jul 25, 2026
Germany
Dabogratinib
1 G Jul 23, 2026
Lithuania
TYRA-300
100 G Jul 21, 2026
Canada
Tyra-300
10 G Jul 20, 2026
Germany
Tyra-300
1 G Jul 19, 2026
Poland
Tyra-300
500 MG Jul 19, 2026
Cyprus
TYRA-300
1 G Jul 13, 2026
Germany
dabogratinib Tyra 300
1 G Jul 12, 2026
Uzbekistan
TYRA-300
1 G Jul 11, 2026
Paraguay
TYRA-300
1 KG Jun 24, 2026
United States
Tyra-300
1 G Jun 8, 2026 Post an enquiry for this product
